Now showing items 1-5 of 5

    • The effect of the tumor environment on the anti-tumor immune response 

      Culp, W David (Institutionen för onkologi-patologi / Department of Oncology-Pathology, 2006-08-28)
      Cancer immunotherapy is the process of stimulating the host's immune system to kill cancer cells, and it is being investigated as adjuvant therapy to traditional cancer treatments such as, surgery, radiation therapy and ...
    • HHV-8/KSHV association with tumor cells during development of Kaposi sarcoma 

      Pak, Fatemeh (Institutionen för onkologi-patologi / Department of Oncology-Pathology, 2006-01-12)
      Kaposi's sarcoma (KS) is a highly and abnormally vascularized tumor-like lesion which usually presents as a cutaneous disease and progresses to extracutaneous, systemic spread usually in the gastrointestinal (GI) tract, ...
    • Chemical transformation of the anticancer drug oxaliplatin 

      Jerremalm, Elin (Institutionen för onkologi-patologi / Department of Oncology-Pathology, 2005-09-02)
      Oxaliplatin is a new platinum based cytostatic drug. It is used in combination with 5-fluorouracil and leucovorin, both as palliative and adjuvant treatment of metastatic colorectal cancer. Various biotransformation products ...
    • Strategies to increase effectiveness of growth factor receptors-targeted therapy in glioblastoma 

      Carapancea, Mia (Institutionen för onkologi-patologi / Department of Oncology-Pathology, 2007-11-14)
      Gliomas are the most common glial neoplasms, accounting for nearly 70% of all primary brain tumours. The progression of low-grade gliomas into more aggressive tumours is supported by the abnormal function of several prot ...
    • Analysis of HLA-A2 frequency as prognostic and/or risk factors in ovarian cancer patients 

      Gamzatova, Zaynab (Institutionen för onkologi-patologi / Department of Oncology-Pathology, 2007-03-21)
      Major histocompatibility complex antigens are mandatory for the immune response, and genetic imbalance may be linked to tumour escape. The HLA-A2 allele in Scandinavia has a high prevalence; it decreases with latitude and ...